OBJECTIVES: Adrenergic modulation of immunity has been extensively characterized, however, few information exist regarding polymorphonuclear leukocytes (PMN), despite their key role in immunity and inflammation. We investigated the effect of adrenergic agents on human PMN migration, CD11b and CD18 expression, reactive oxygen species (ROS) and interleukin (IL)-8 production, and on adrenoceptor (AR) expression. METHODS: Migration was measured by the Boyden chamber assay, CD11b/CD18 expression was assessed by flow cytometry, intracellular ROS were detected by spectrofluorimetry, and IL-8 was quantitated by standard ELISA assay. AR mRNA levels were measured by real-time PCR and PMN morphology was studied by scanning electron microscopy. RESULTS: Adrenaline(A), noradrenaline and the β-AR agonist isoprenaline reduced N-formyl-Met-Leu-Phe (fMLP)-induced migration, CD11b/CD18 expression, and ROS production, without affecting IL-8. The effect of A on CD11b was antagonized by yohimbine and propranolol, and increased by prazosin. The effect on ROS production was completely abolished by propranolol. PMN expressed α(1A)-, α(1B)-, α(1D)-, α(2A)-, α(2C)-, β(1)-, β(2)-, and β(3)-AR mRNA. A prevented fMLP-induced morphological changes of PMN. CONCLUSIONS: Adrenergic agents reduced PMN responses mainly through β-AR, although α-AR may contribute at least to CD11b expression. AR-operated pathways in PMN should be investigated in disease conditions and in the response to therapeutic agents.
OBJECTIVES: Adrenergic modulation of immunity has been extensively characterized, however, few information exist regarding polymorphonuclear leukocytes (PMN), despite their key role in immunity and inflammation. We investigated the effect of adrenergic agents on human PMN migration, CD11b and CD18 expression, reactive oxygen species (ROS) and interleukin (IL)-8 production, and on adrenoceptor (AR) expression. METHODS: Migration was measured by the Boyden chamber assay, CD11b/CD18 expression was assessed by flow cytometry, intracellular ROS were detected by spectrofluorimetry, and IL-8 was quantitated by standard ELISA assay. AR mRNA levels were measured by real-time PCR and PMN morphology was studied by scanning electron microscopy. RESULTS:Adrenaline(A), noradrenaline and the β-AR agonist isoprenaline reduced N-formyl-Met-Leu-Phe (fMLP)-induced migration, CD11b/CD18 expression, and ROS production, without affecting IL-8. The effect of A on CD11b was antagonized by yohimbine and propranolol, and increased by prazosin. The effect on ROS production was completely abolished by propranolol. PMN expressed α(1A)-, α(1B)-, α(1D)-, α(2A)-, α(2C)-, β(1)-, β(2)-, and β(3)-AR mRNA. A prevented fMLP-induced morphological changes of PMN. CONCLUSIONS: Adrenergic agents reduced PMN responses mainly through β-AR, although α-AR may contribute at least to CD11b expression. AR-operated pathways in PMN should be investigated in disease conditions and in the response to therapeutic agents.
Authors: Maren S Fragala; William J Kraemer; Andrea M Mastro; Craig R Denegar; Jeff S Volek; Keijo Häkkinen; Jeffrey M Anderson; Elaine C Lee; Carl M Maresh Journal: Med Sci Sports Exerc Date: 2011-08 Impact factor: 5.411
Authors: Ada María Herrera-García; María Jesús Domínguez-Luis; María Arce-Franco; Estefanía Armas-González; Diego Álvarez de La Rosa; José David Machado; Martina K Pec; Manuel Feria; Olga Barreiro; Francisco Sánchez-Madrid; Federico Díaz-González Journal: J Immunol Date: 2014-08-11 Impact factor: 5.422
Authors: M Cosentino; F Marino; S Cattaneo; L Di Grazia; C Francioli; A M Fietta; S Lecchini; G Frigo Journal: J Leukoc Biol Date: 2000-05 Impact factor: 4.962
Authors: G N Gurguis; R Andrews; D Antai-Otong; S P Vo; J E Blakeley; P J Orsulak; A J Rush Journal: Psychopharmacology (Berl) Date: 1999-04 Impact factor: 4.530
Authors: Irena Brunskole Hummel; Michael T Reinartz; Solveig Kälble; Heike Burhenne; Frank Schwede; Armin Buschauer; Roland Seifert Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240
Authors: Rangel L Silva; Fernanda V Castanheira; Jozi G Figueiredo; Gabriel S Bassi; Sérgio H Ferreira; Fernando Q Cunha; Thiago M Cunha; Alexandre Kanashiro Journal: Inflammation Date: 2016-08 Impact factor: 4.092